Jump to ContentJump to Main Navigation
The ESC Textbook of Intensive and Acute Cardiac Care$
Users without a subscription are not able to see the full content.

Edited by Marco Tubaro, Nicolas Danchin, Gerasimos Filippatos, Patrick Goldstein, Pascal Vranckx, Doron Zahger

European Society of Cardiology Acute Cardiac Care ESC Working Group Acute Cardiovassular Care Associations

CME Assessment

Click here for more information and links to available questions.

Access token activation

Click here to activate your access token for this title.

References

All references in the book are available to download for free.

Subscriber Login

Forgotten your password?

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Contents

Special considerations in immunosuppressed patients

Chapter:
Special considerations in immunosuppressed patients
Author(s):

Alain Durocher,

Raphaël Favory

DOI:
10.1093/med/9780199584314.003.0076

Many patients encountered in the intensive care unit (ICU) are immunosuppressed. Immunosuppression may be caused by an underlying disease (e.g. haematological disease), by treatment (drugs to prevent organ rejection), or as a side effect of chemotherapy.

The immune system is generally plays a successful role in maintaining the integrity of the individual. It is made up of integumental function, the innate immune response, and the adaptive immune response. Immune function is not static and can change over the period of illness in some patients. Immunosuppression in itself does not cause pathology, but leaves the patient prone to infection, which is the cause of morbidity and mortality in immunosuppressed patients. This highlights the importance of infection control, the most important aspect of which is prevention.

The most important intervention is the timely initiation of appropriate antimicrobial therapy. Sending adequate and appropriate samples to the microbiology laboratory is also important in the management of an infected immunosuppressed patient.

In organ recipients, the required immunosuppression increases the risk of infection and can also make the onset of symptoms insidious.

Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.